Antiseizure Medications Linked to Serious Potential Reaction, FDA Warns
Levetiracetam and clobazam can cause Drug Reaction with Eosinophilia and Systemic Symptoms, which can start as a rash but progress quickly, potentially resulting in injury to internal organs, hospitalization, and death.
Pharmacists Must Join Advocacy Efforts to Help Move the Profession Forward
Drug Topics recently sat down with Steve Hoffart, PharmD, owner and PIC at Magnolia Pharmacy north of Houston, to discuss the importance of pharmacists getting involved in advocacy.
Examining Barriers to Care in Diabetic Retinopathy Screening
Prior research has shown the association between various socioeconomic variables and lower adherence to diabetic retinopathy screening, but few have elaborated on the patient perspective to understand the reason behind this association.
Podcast: Is The Pharmacy World Prepared For DSCSA?
Todd Eury of the Pharmacy Podcast Network is joined by Josh Bolin of the NABP to talk about DSCSA, what benefits it will provide, and how to make sure your pharmacy is ready when it goes into effect this November.
FDA: Roflumilast Cream sNDA Accepted for Atopic Dermatitis
The treatment from Arcutis Biotherapeutics has a Prescription Drug User Fee Act (PDUFA) target action date of July 7, 2024.
2022-2023 Influenza Season Classified as High Severity by CDC
This season marks the fourth to be classified as high severity since the 2009 influenza A(H1N1) pandemic.
2 Clarke Drive Cranbury, NJ 08512